GURUFOCUS.COM » STOCK LIST » USA » NAS » Vir Biotechnology Inc (NAS:VIR) » Definitions » Profitability Rank
Switch to:

Vir Biotechnology (NAS:VIR) Profitability Rank

: 1 (As of Sep. 2022)
View and export this data going back to 2019. Start your Free Trial

Vir Biotechnology has the Profitability Rank of 1. It has had trouble to make a profit.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Vir Biotechnology's Operating Margin % for the quarter that ended in Sep. 2022 was 52.49%. As of today, Vir Biotechnology's Piotroski F-Score is 7.


Vir Biotechnology (NAS:VIR) Profitability Rank Competitive Comparison

For the Biotechnology subindustry, Vir Biotechnology's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Vir Biotechnology (NAS:VIR) Profitability Rank Distribution

For the Biotechnology industry and Healthcare sector, Vir Biotechnology's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Vir Biotechnology's Profitability Rank falls into.



Vir Biotechnology Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Vir Biotechnology has the Profitability Rank of 1. It has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Vir Biotechnology's Operating Margin % for the quarter that ended in Sep. 2022 is calculated as:

Operating Margin %=Operating Income (Q: Sep. 2022 ) / Revenue (Q: Sep. 2022 )
=194.964 / 371.432
=52.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Vir Biotechnology has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Vir Biotechnology Profitability Rank Related Terms

Thank you for viewing the detailed overview of Vir Biotechnology's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Vir Biotechnology (NAS:VIR) Business Description

Vir Biotechnology logo
Traded in Other Exchanges
Address
499 Illinois Street, Suite 500, San Francisco, CA, USA, 94158
Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue.
Executives
Friedl-naderer Johanna officer: Chief Business Officer, Global C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158
Arch Venture Partners Ix Overage, L.p. 10 percent owner 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Crandell Keith 10 percent owner 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Nelsen Robert director, 10 percent owner 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Bybee Clinton 10 percent owner 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Arch Venture Fund Ix Overage, L.p. 10 percent owner 8725 W. HIGGINS ROAD, SUITE 290 CHICAGO IL 60631
Arch Venture Fund Ix, L.p. 10 percent owner 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Arch Venture Partners Ix, L.p. 10 percent owner 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Arch Venture Partners Ix, Llc 10 percent owner 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Hanly Ann M. officer: Chief Technology Officer C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158
Hatfield Jeffrey S. director 11080 ROSELLE STREET SAN DIEGO CA 92121
Napolitano Janet director C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158
Rice Steven J. officer: Chief Administrative Officer C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158
Sigal Charles Elliott director 32 BREARLY ROAD PRINCETON NJ 08540
V-sciences Investments Pte Ltd 10 percent owner 60B ORCHARD ROAD #06-18 THE [email protected] SINGAPORE U0 238891

Vir Biotechnology (NAS:VIR) Headlines

From GuruFocus

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
premium membership